50 Years of Excellence: Travelers Summer Research Fellowship
February 22, 2019 On the heels of the civil rights movement, a small, Ivy League medical school in New York City, long committed to advancing diversity in medicine and science, launched a summer fellowship program designed to do just that.
Most Causes of Healthcare Fragmentation Not Related to Medical Need
February 20, 2019 Most of the reasons why American patients receive care from multiple providers are related to numerous modifiable causes such as patient preferences, physician referrals and health system factors —not medical need—according to a qualitative study by Weill Cornell Medicine researchers.  
Diverse Teams Converge to Solve Healthcare Problems at Weekend Hackathon
February 15, 2019 The third annual NYC Health Hackathonbrought together nearly 200 students and faculty members from Weill Cornell Medicine, Cornell’s Ithaca campus, and several local and national academic institutions, to develop high-tech healthcare innovations. 
Researchers Create the First Anatomical Map of Innate Lymphoid Cells in Healthy Human Tissues
February 12, 2019 Researchers have long known that dysfunction in the body’s innate immune system breaks the first line of defense against invading pathogens, enabling diseases to flourish unchecked.
Cornell Creates Multicollege Center for Immunology
February 11, 2019 Building on Cornell’s decades of fundamental and comparative research in the immunological sciences, Provost Michael Kotlikoff has announced the creation of a new Cornell Center for Immunology.
Delivering Hope
February 8, 2019 Diffuse Intrinsic Pontine Glioma (DIPG) is every parent’s worst nightmare: a rare and incurable type of brain cancer that affects young children. Dr. Mark Souweidane decided to make curing this cancer his “Holy Grail”—and his progress since then has been impressive.
Chelsea Clinton Shares Her Insights on Public Health
February 8, 2019 Chelsea Clinton is a public health advocate, researcher and educator. But being a mother has deepened her passion for children’s health, she explained in a talk on Feb. 5 at Weill Cornell Medicine.
New Antimicrobial Resistance Mechanism Uncovered in Hunt for TB New Drug
February 6, 2019 An investigation by Weill Cornell Medicine scientists has yielded two breakthroughs in the pursuit of combating growing resistance to tuberculosis treatments. 
Dr. Joseph J. Fins Wins Award from the American College of Physicians
January 31, 2019 Dr. Joseph J. Fins, chief of the Division of Medical Ethics at Weill Cornell Medicine, has been awarded the Nicholas E. Davies Memorial Scholar Award from the American College of Physicians, a national organization of internists.
Immunotherapy May Help Patients with Advanced Esophageal Cancer
January 29, 2019 Treating patients with advanced, metastatic esophageal cancer with an immune-system boosting drug called pembrolizumab, known by its brand name Keytruda, led to regression of tumors in some patients, according to results of a phase 2 clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

Calendar of Events